The private placement to Swedish Growth Fund was registered with Bolagsverket on January 22, 2018

January 23, 2018

The private placement to Swedish Growth Fund was registered with Bolagsverket on January 22, 2018

The private placement corresponds to 1 446 280 new shares.

The number of shares after the issue is now 28 121 566 and the company’s share capital after the issue is 3 374 587.92. For further information about the issue, see press release on November 1st, 2017.

For more information, please contact:
Jan Alenfall – VD, Follicum AB
Telephone: 046 -19 21 97
E-mail: info@follicum.com

About Follicum AB
Follicum is a biotech company focused on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial. In diabetes, the drug candidate FOL-014 has demonstrated an increase in insulin release in pre-clinical models. The company was founded in 2011, and is based in Lund, Sweden. Follicum is listed on the Swedish small cap exchange Aktietorget since 2014. www.follicum.com

Open Press Release